Published in Proc Natl Acad Sci U S A on February 01, 1982
Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex. J Exp Med (1983) 9.23
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54
Cell-free translation of a biologically active, antigen-specific suppressor T cell factor. Proc Natl Acad Sci U S A (1982) 1.06
Special regulatory T-cell review: A rose by any other name: from suppressor T cells to Tregs, approbation to unbridled enthusiasm. Immunology (2008) 0.97
Functional roles of two polypeptide chains that compose an antigen-specific suppressor T cell factor. J Exp Med (1984) 0.94
Structural analysis of antigen-specific Ia-bearing regulatory T-cell factors: gel electrophoretic analysis of the antigen-specific augmenting T -cell factor. Proc Natl Acad Sci U S A (1983) 0.92
Human T cell hybridomas secreting immune interferon. Proc Natl Acad Sci U S A (1982) 0.89
Dengue virus-induced helper cytokine has two polypeptide chains which bear different determinants. Int J Exp Pathol (1991) 0.88
Differentiation of human T-lymphoid leukemia cells into cells that have a suppressor phenotype is induced by phorbol 12-myristate 13-acetate. Proc Natl Acad Sci U S A (1982) 0.84
Partial purification and characterization of an antigen-specific helper factor synthesized by a T-cell continuous line. Proc Natl Acad Sci U S A (1983) 0.83
Purification and characterization of an L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT)-specific suppressor factor from genetic responder mice. J Exp Med (1983) 0.79
Functional and biochemical characterization of a secreted I-J(+) suppressor factor that binds to immunoglobulin. J Exp Med (1986) 0.78
Binding of the two polypeptide chains of dengue virus-induced suppressor cytokine to its receptor isolated from macrophages. Int J Exp Pathol (1993) 0.77
Identification of Igh-C-linked determinants on suppressor T cell hybrids and factors specific for L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Exp Med (1985) 0.75
Molecular genetic characterization of the mRNA coding for an inducible suppressor factor specific for L-glutamic acid60-L-alanine30-L-tyrosine10. Proc Natl Acad Sci U S A (1987) 0.75
Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (1970) 1528.65
A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem (1980) 24.76
Antibodies to major histocompatibility antigens produced by hybrid cell lines. Nature (1977) 16.54
Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system. J Biol Chem (1971) 16.34
Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med (1974) 5.55
A single major pathway of T-lymphocyte interactions in antigen-specific immune suppression. Scand J Immunol (1981) 3.85
Immunological circuits: cellular composition. Fed Proc (1979) 3.72
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol (1976) 3.64
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
A cellular basis for genetically controlled immunologic unresponsiveness in mice: tolerance induction in T-cells. Proc Natl Acad Sci U S A (1973) 2.52
Shared idiotypic determinants on antibodies and T-cell-derived suppressor factor specific for the random terpolymer L-glutamic acid60-L-alanine30-L-tyrosine10. J Exp Med (1979) 2.51
Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor. J Exp Med (1980) 2.41
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
Mapping the H-2-linked genes governing, respectively, the immune responses to a glutamic acid-alanine-tyrosine copolymer and to limiting doses of ovalbumin. J Immunol (1973) 2.07
Antigen-specific T lymphocyte clones. II. Purification and biological characterization of an antigen-specific suppressive protein synthesized by cloned T cells. J Exp Med (1981) 1.86
Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin. Proc Natl Acad Sci U S A (1977) 1.86
Functional and molecular organisation of an antigen-specific suppressor factor from a T-cell hybridoma. Nature (1980) 1.84
Cellular consequences in the suppression of antibody response by the antigen-specific T-cell factor. J Exp Med (1980) 1.38
High-performance liquid chromatography and picomole-level detection of peptides and proteins. Methods Enzymol (1981) 1.30
Immunosuppressive factor(s) from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). V. Inhibition of T cell proliferative responses. J Immunol (1980) 1.04
Fluorescamine: a reagent for assay of amino acids, peptides, proteins, and primary amines in the picomole range. Science (1972) 11.71
Fluorometric assay of proteins in the nanogram range. Arch Biochem Biophys (1973) 7.81
Genetic control of immune responses in vitro. V. Stimulation of suppressor T cells in nonresponder mice by the terpolymer L-glutamic acid 60-L-alanine 30-L-tyrosine 10 (GAT). J Exp Med (1974) 5.55
Comparison of treatment of renal calculi by open surgery, percutaneous nephrolithotomy, and extracorporeal shockwave lithotripsy. Br Med J (Clin Res Ed) (1986) 3.99
Immunosuppressive factor(s) extracted from lymphoid cells of nonresponder mice primed with L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT). J Immunol (1976) 3.64
Purification and properties of a type beta transforming growth factor from bovine kidney. Biochemistry (1983) 3.49
Regulation of the immune response by prostaglandins. Clin Immunol Immunopathol (1980) 3.21
Molecular cloning and sequence determination of DA strain of Theiler's murine encephalomyelitis viruses. Virology (1988) 3.17
Genetic control of specific immune suppression. II. H-2-linked dominant genetic control of immune suppression by the random copolymer L-glutamic acid50-L-tyrosine50 (GT). J Exp Med (1975) 3.17
Regulation by the H-2 gene complex of macrophage-lymphoid cell interactions in secondary antibody responses in vitro. J Exp Med (1976) 3.10
Glucose metabolism in Neisseria gonorrhoeae. J Bacteriol (1974) 3.01
Genetic control of immune responses in vitro. 3. Tolerogenic properties of the terpolymer L-glutamic acid 60-L-alanine30-L-tyrosine10 (GAT) for spleen cells from nonresponder (H-2s and H-2q) mice. J Exp Med (1974) 3.01
Automatic Monitoring of primary amines in preparative column effluents with fluorescamine. Anal Biochem (1975) 2.88
Genetic control of specific immune suppression. I. Experimental conditions for the stimulation of suppressor cells by the copolymer L-glutamic acid50-L-tyrosine50 (GT) in nonresponder BALB/c mice. J Exp Med (1975) 2.78
Regulation of murine lymphokine production in vivo. III. The lymphoid tissue microenvironment exerts regulatory influences over T helper cell function. J Exp Med (1990) 2.58
Suppression of antibody and T cell proliferative responses to L-glutamic acid60-L-alanine30-L-tyrosine10 by a specific monoclonal T cell factor. J Exp Med (1980) 2.41
Infectious cDNA clones of the DA strain of Theiler's murine encephalomyelitis virus. J Virol (1989) 2.31
Amino acid analysis with fluorescamine at the picomole level. Arch Biochem Biophys (1973) 2.23
Identification of the alpha subunit half-cystine specifically labeled by an affinity reagent for the acetylcholine receptor binding site. J Biol Chem (1984) 2.17
Neurovirulence determinants of genetically engineered Theiler viruses. Proc Natl Acad Sci U S A (1990) 2.15
The Leicester Risk Assessment score for detecting undiagnosed Type 2 diabetes and impaired glucose regulation for use in a multiethnic UK setting. Diabet Med (2010) 2.09
Long-term survival after Edmonston-Zagreb measles vaccination in Guinea-Bissau: increased female mortality rate. J Pediatr (1993) 2.08
Immunosuppressive factor(s) specific for L-glutamic acid50-L-tyrosine50 (GT). III. Generation of suppressor T cells by a suppressive extract derived from GT-primed lymphoid cells. J Exp Med (1977) 2.08
Epithelial to mesenchymal transition (EMT) biomarkers--E-cadherin, beta-catenin, APC and Vimentin--in oral squamous cell carcinogenesis and transformation. Oral Oncol (2012) 1.98
Different functional specificity repertoires for suppressor and helper T cells. Immunol Rev (1978) 1.91
Isolation and characterization of the opioid peptides from rat pituitary: beta-lipotropin. Proc Natl Acad Sci U S A (1977) 1.86
Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells. Proc Natl Acad Sci U S A (1998) 1.84
Females in proestrus state maintain splenic immune functions and tolerate sepsis better than males. Crit Care Med (1997) 1.83
An about 50,000-dalton protein in adrenal medulla: a common precursor of [Met]- and [Leu]enkephalin. Science (1980) 1.81
Characterization of recombinant human interleukin-2 with micromethods. J Chromatogr (1985) 1.76
Regulation of immune responses by suppressor T cells. Tohoku J Exp Med (1976) 1.73
Effects of unemployment on mental and physical health. Am J Public Health (1985) 1.71
Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol (1980) 1.70
Contrasting effects of glucocorticoids on the capacity of T cells to produce the growth factors interleukin 2 and interleukin 4. Eur J Immunol (1989) 1.68
The steinstrasse: A legacy of extracorporeal lithotripsy? 1988. Eur Urol (2006) 1.67
Antigen stimulation of prostaglandin synthesis and control of immune responses. Proc Natl Acad Sci U S A (1976) 1.67
A phase II study of lapatinib monotherapy in chemotherapy-refractory HER2-positive and HER2-negative advanced or metastatic breast cancer. Ann Oncol (2008) 1.66
Extracorporeal shock wave lithotripsy: the first 50 patients treated in Britain. Br Med J (Clin Res Ed) (1985) 1.66
The stimulation of specific suppressor T cells in genetic non-responder mice by linear random copolymers of L-amino acids. Transplant Rev (1975) 1.64
Aspartic acid-484 of nascent placental alkaline phosphatase condenses with a phosphatidylinositol glycan to become the carboxyl terminus of the mature enzyme. Proc Natl Acad Sci U S A (1988) 1.64
Putative enkephalin precursors in bovine adrenal medulla. Biochem Biophys Res Commun (1979) 1.63
Theiler's murine encephalomyelitis virus neutralization escape mutants have a change in disease phenotype. J Virol (1989) 1.62
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide. Proc Natl Acad Sci U S A (2005) 1.60
RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci U S A (1983) 1.54
COOH-terminal requirements for the correct processing of a phosphatidylinositol-glycan anchored membrane protein. J Biol Chem (1988) 1.52
Immune responses in vitro. X. Functions of macrophages. J Immunol (1974) 1.47
Bone density in haemophilia: a single institutional cross-sectional study. Haemophilia (2013) 1.47
Isolation of the opioid heptapeptide Met-enkephalin [Arg6,Phe7] from bovine adrenal medullary granules and striatum. Proc Natl Acad Sci U S A (1979) 1.47
Isolation and characterization of the opioid peptides from rat pituitary: beta-endorphin. Proc Natl Acad Sci U S A (1977) 1.47
Preparation of oligonucleotide-peptide conjugates. Bioconjug Chem (1992) 1.47
ALFRED: the ALelle FREquency Database. Update. Nucleic Acids Res (2003) 1.46
Triggering of New Madrid seismicity by late-Pleistocene erosion. Nature (2010) 1.44
Biosynthesis of glycosylphosphatidylinositol (GPI)-anchored membrane proteins in intact cells: specific amino acid requirements adjacent to the site of cleavage and GPI attachment. J Cell Biol (1993) 1.43
Surgical site infection rates: open versus hand-assisted colorectal resections. Tech Coloproctol (2013) 1.41
Retropubic extraperitoneal endoscopy. Med J Aust (1993) 1.40
Active site of human liver aldehyde dehydrogenase. Biochemistry (1987) 1.40
The regulation of the immune response to T-independent antigens by prostaglandins and B cells. J Immunol (1976) 1.40
Shifts in diagnostic frequencies of schizophrenia and major affective disorders at six North American psychiatric hospitals, 1972-1988. Am J Psychiatry (1993) 1.40
Use of pediatric physician extenders in pediatric and neonatal intensive care units. Crit Care Med (1994) 1.40
Gamma delta T lymphocytes regulate the induction and maintenance of oral tolerance. J Immunol (1997) 1.39
An active carbonyl formed during glycosylphosphatidylinositol addition to a protein is evidence of catalysis by a transamidase. J Biol Chem (1995) 1.38
Altered regulation of IL-6 production with normal aging. Possible linkage to the age-associated decline in dehydroepiandrosterone and its sulfated derivative. J Immunol (1993) 1.37
Control of mitogen-induced transformation: characterization of a splenic suppressor cell and its mode of action. Cell Immunol (1976) 1.36
Serum alpha 1-antitrypsin variants. Prevalence and clinical spirometry. Am Rev Respir Dis (1973) 1.35
Two adrenal opioid polypeptides: proposed intermediates in the processing of proenkephalin. Proc Natl Acad Sci U S A (1981) 1.34
Resting state in normal and simian virus 40 transformed Chinese hamster lung cells. Proc Natl Acad Sci U S A (1976) 1.33
Humane and practical implications of using carbon dioxide mixed with oxygen for anesthesia or euthanasia of rats. Lab Anim Sci (1997) 1.32
Probable precursors of [Leu]enkephalin and [Met]enkephalin in adrenal medulla: peptides of 3-5 kilodaltons. Proc Natl Acad Sci U S A (1980) 1.32
Biosynthesis of phosphatidylinositol glycan-anchored membrane proteins. Design of a simple protein substrate to characterize the enzyme that cleaves the COOH-terminal signal peptide. J Biol Chem (1991) 1.31
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides. J Control Release (2003) 1.31
Mitogen-induced changes in lymphocyte prostaglandin levels: a signal for the induction of suppressor cell activity. Cell Immunol (1978) 1.31
T and B cells that recognize the same antigen do not transcribe similar heavy chain variable region gene segments. J Exp Med (1983) 1.31
Functional heterogeneity among the T-derived lymphocytes of the mouse. II. Sensitivity of subpopulations to anti-thymocyte serum. J Immunol (1975) 1.31
High-performance liquid chromatography and picomole-level detection of peptides and proteins. Methods Enzymol (1981) 1.30
Amino acid sequence of a human leukocyte interferon. Proc Natl Acad Sci U S A (1981) 1.29
Binding assay for opioid peptides with neuroblastoma x glioma hybrid cells: specificity of the receptor site. Brain Res (1978) 1.29
Noscapine inhibits tumor growth with little toxicity to normal tissues or inhibition of immune responses. Cancer Immunol Immunother (2000) 1.28
Secondary antibody responses in vitro to L-glutamic acid60-L-alanine30-L-tyrosine10 (GAT) by (responder X nonresponder)F1 spleen cells stimulated by parental GAT-macrophages. J Exp Med (1977) 1.26
Immune responses in vitro. XI. Suppression of primary IgM and IgG plaque-forming cell responses in vitro by alloantisera against leukocyte alloantigens. J Exp Med (1974) 1.24
Relationship between effects on time-to-disease progression and overall survival in studies of metastatic breast cancer. Br J Cancer (2008) 1.23
Comparative pulmonary toxicity of gallium arsenide, gallium(III) oxide, or arsenic(III) oxide intratracheally instilled into rats. Toxicol Appl Pharmacol (1986) 1.22
Exogenous antigens gain access to the major histocompatibility complex class I processing pathway in B cells by receptor-mediated uptake. J Exp Med (1996) 1.21
Vaginal degeneration following implantation of synthetic mesh with increased stiffness. BJOG (2013) 1.19
Regulation of murine lymphokine production in vivo. II. Dehydroepiandrosterone is a natural enhancer of interleukin 2 synthesis by helper T cells. Eur J Immunol (1990) 1.19
Receptor diversity of insulin-specific T cell lines from C57BL (H-2b) mice. J Immunol (1987) 1.19
H-2 linked Ir gene control of antibody responses to porcine insulin. I. Development of insulin-specific antibodies in some but not all nonresponder strains injected with proinsulin. J Immunol (1978) 1.18
High molecular weight opioid-containing proteins in striatum. Proc Natl Acad Sci U S A (1978) 1.18
Resection of gastrinomas. Ann Surg (1983) 1.18
A highly potent 3200-dalton adrenal opioid peptide that contains both a [Met]- and [Leu]enkephalin sequence. Proc Natl Acad Sci U S A (1981) 1.18